Diagnostics & Imaging

TinyAI

Microbiome intelligence engine that interprets longitudinal gut microbiome results across life stages.

The Signal

Introduced with Tiny Health's $33 million Series B on September 29, 2026, with Gut Microbiome Age and Gut Resilience metrics.

AI-driven triage and notification software for detecting acute abnormalities in medical imaging scans.

Care coordination platform using artificial intelligence to identify strokes and other vascular diseases.

AI-powered radiology solutions for detecting lung abnormalities and breast cancer on chest X-rays.

FDA-cleared digital pathology software utilizing artificial intelligence to assist pathologists in cancer detection.

Ambulatory cardiac monitoring service using wearable biosensors and cloud-based data analytics.

AI-powered pathology analysis tools for drug development and diagnostic accuracy in clinical trials.